ZEB1 and neoplasm: In patient 2 (primary FL to relapse FL after a 2-year gap), there was a significant increase in Tumor B1 cells (from 2.89% to 74.56%), indicating that TFs enriched in Tumor B1, such as ZEB1, SNAI2, and ID4, may drive FL relapse.